Start the conversation
There's an under-the-radar reason why the stock market keeps rallying despite some mediocre economic numbers, constant "noise" out of Washington, and plenty of overheated valuations.
And while it's a bit hidden, it's huge.
In fact, it owned 6% of the U.S. stock market in the first quarter.
And it keeps gobbling things up.
It bought $98 billion in U.S. stocks during the first three months of the year – and that puts it on pace to surpass its total purchases for 2015 and '16 combined.
I'm talking about exchange-traded funds (ETFs) and Main Street investors' big appetite for passive investments.
Those investors keep putting more money into funds they can then forget about – and the market keeps rising.
Now, you could join them and buy some passive index funds.
But that's not what we do here. We're in search of investments on the frontier – ones that will double, triple… even quadruple our money.
So let's get active and go in search of three ETFs that will get us to that frontier.
All three will continue to double the market's return – and line your pockets – for years to come…
While we're active stock pickers at Strategic Tech Investor, I do recommend making several tech ETFs part of your core holdings because they target the most profitable trends and give you instant diversification.
Plus, they take advantage of the fact that tech remains one of the big drivers in this bull market that began in March 2009. Even though we do see the sector come under pressure from time to time, as it did again a couple of weeks ago, technology remains the best place to make life-changing gains.
And to get yourself on the Road to Wealth…
Again, I'm not saying you should avoid individual stocks. We use ETFs to provide a solid base so that you can focus on the big winners among individual tech shares.
That's where my two paid services come into play. We just closed the books on the second quarter and totally crushed the market.
During the period, the S&P 500 gained 2.6%. But readers at my Nova-X Report more than tripled that, with an average gain of 8.1%. Members of my Radical Technology Profits premium service did even better. They earned an average 12.9% return, beating the broad market by just shy of fivefold.
Several stocks at each service did even better than that, with some climbing 30% or more in just three months.
Now, let's make sure you add to your foundational holdings by taking advantage of the big upsurge we see in ETF investing.
But let's do so actively.
I've come up with three that are focused on high tech and that have great returns and very low overhead – they pass all three of my ETF Profit Screens. That means your profits won't get eaten by expenses.
If you ever thought ETFs couldn't get you to the frontier – think again.
Take a look at these three…
Frontier ETF No. 1
The SPDR S&P Semiconductor ETF (NYSE Arca: XSD) is a great play on a very basic fact – our tech-driven world needs chips for just about everything, from smartphones and connected cars to Wi-Fi routers and data centers.
Add in the Internet of Everything, virtual reality, and artificial intelligence – and you can see we're looking at strong demand for years to come.
With XSD, we get to invest in roughly 50 firms covering nearly every aspect of the chip sector.
Nvidia Corp. (Nasdaq: NVDA) makes advanced graphics processors now being used in connected cars, virtual reality, and artificial intelligence. And Integrated Device Technology Inc. (Nasdaq: IDTI) is a small-cap firm that sells sophisticated computer memory systems to the wireless industry.
No wonder XSD is such a strong performer. Over the past year, it has soared roughly 41%, more than double the gains of the S&P 500. XSD trades at $62, with an expense ratio of 0.35%.
Frontier ETF No. 2
Holding more than 40 stocks, First Trust Dow Jones Internet Index (NYSE Arca: FDN) is set up to take advantage of the broad changes occurring in the Internet industry, including a nice sub-focus on e-commerce.
Plus, FDN holds web "pick-and-shovel plays" like Netgear Inc. (Nasdaq: NTGR), which supplies Ethernet switches to homes, businesses, and Internet service providers.
For the year ended June 30, FDN is up roughly 31%, right at double the gains of the S&P 500. It trades at roughly $94 and has a 0.54% expense ratio.
Frontier ETF No. 3
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.